Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an investigational Ayurvedic herbal compound preparation developed by the University of Duisburg-Essen for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). The preparation consists of three active herbal ingredients: *Murraya koenigii* (curry leaves), *Punica granatum* (pomegranate), and *Curcuma longa* (turmeric). It is administered as a decoction (tea) made from ground powders of these three plants. A randomized, double-blind, placebo-controlled crossover trial (NCT01418066) was conducted between 2011 and 2012 to evaluate its feasibility, safety, and efficacy. The study concluded that while the herbal preparation was safe with only minor adverse events reported, it was no more effective than placebo in improving IBS-D symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Murraya koenigii + Punica granatum + Curcuma longa.